Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Journal of Anesthesia
Erschienen in: Journal of Anesthesia 6/2010

01.12.2010 | Review Article

Colloid solutions: a clinical update

verfasst von: Tomi T. Niemi, Ryo Miyashita, Michiaki Yamakage

Erschienen in: Journal of Anesthesia | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Albumin, dextran, gelatin, and hydroxyethyl starch (HES) solutions are colloids that efficiently expand the circulating blood volume. The administration of colloids restores the intravascular volume with minimal risk of tissue edema in comparison with crystalloid solutions alone. However, colloids are always given for surgical and critically ill patients. The type of the colloid, volumes applied, aggressiveness of fluid resuscitation, and the volume status at the initial phase of administration determine their clinical responses. The outcome after fluid resuscitation with various colloids in critically ill patients seems to be comparable according to systematic reviews. A randomized, adequately powered clinical trial comparing modern nonprotein colloid to albumin is still lacking. Rapidly degradable HES solutions have good hemodynamic effects, and the risk of adverse renal and coagulation effects, as well as allergic reactions, is minimal. The current investigation has also shown the beneficial effect of HES solution (especially HES 130/0.4) on inflammatory response, postoperative nausea and vomiting, and postoperative outcome. The indication of colloids with an assessment of the degree of hypovolemia and safety profiles should thus be taken into consideration before colloid administration.
Literatur
1.
2.
Perner A, Åneman A, Guttormsen AB, Kárason S, Tenhunen J. Preferences for colloid use in Scandinavian intensive care units. Acta Anaesthesiol Scand. 2008;52:750–8.CrossRef
3.
Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008;109:723–40.PubMedCrossRef
4.
Grocott MP, Mythen MG, Gan TJ. Perioperative fluid management and clinical outcomes in adults. Anesth Analg. 2005;100:1093–106.PubMedCrossRef
5.
6.
Hiippala S, Linko K, Myllylä G, Lalla M, Hekali R, Makelainen A. Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Acta Anaesthesiol Scand. 1995;39:228–35.PubMedCrossRef
7.
Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–66.PubMedCrossRef
8.
Barron ME, Wilkes M, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg. 2004;139:552–63.PubMedCrossRef
9.
Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence risk factors mechanisms. A French multicenter prospective study. Ann Fr Anest Reanim. 1994;13:301–10.
10.
Kohler H, Zschiedrich H, Clasen R, Linfante A, Gamm H. The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure, and renal function in human volunteers. Anaesthetist. 1982;31:61–7.
11.
Ljungström KG. Safety of dextran in relation to other colloids—ten years experience with hapten inhibition. Infus Ther Transfus Med. 1993;20:206–10.
12.
Van der Linden P, Ickx BE. The effects of colloid solutions on hemostasis. Can J Anaesth. 2006;53:S30–9.PubMedCrossRef
13.
Nearman HS, Herman ML. Toxic effects of colloids in the intensive care unit. Crit Care Clin. 1991;7:713–23.PubMed
14.
Kramer GC, Wade CE, Prough DS. Hypertonic saline dextran: efficacy and regulatory approval. Acta Anaesthesiol Scand. 1998;42:141–4.PubMedCrossRef
15.
Peano S, Reiner G, Carbonatto M, Bodenbender L, Boland P, Abel KJ. Determination of the clearance factor for transmissible spongiform encephalopathy agents during the manufacturing process of polygeline. Intensive Care Med. 2000;26:608–12.PubMedCrossRef
16.
Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med. 1999;25:258–68.PubMedCrossRef
17.
Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet. 2005;44:681–99.PubMedCrossRef
18.
Westphal M, James MFM, Kozek-Langenecker S, Stocker R, Guidet B, van Aken H. Hydroxyethyl starches. Anesthesiology. 2009;111:187–202.PubMedCrossRef
19.
Lehmann GB, Asskali F, Boll M, Burmeister MA, Marx G, Hilgers R, Förster H. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth. 2007;98:635–44.PubMedCrossRef
20.
Shatney CH, Chaudry IH. Hydroxyethyl starch administration does not depress reticuloendothelial function or increase mortality from sepsis. Circ Shock. 1994;13:21–6.
21.
Sharland C, Huggett A, Nielson MS, Friedmann PS. Persistent pruritus after pentastarch infusions in intensive care patients. Anaesthesia. 1999;54:500–1.PubMedCrossRef
22.
Morgan PW, Berridge JC. Giving long-persistent starch as volume replacement can cause pruritus after cardiac surgery. Br J Anaesth. 2000;85:696–9.PubMedCrossRef
23.
Christensen P, Andersson J, Rasmussen SE, Andersen PK, Henneberg SW. Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients. Acta Anaesthesiol Scand. 2001;45:414–20.PubMedCrossRef
24.
Rehm M, Haller M, Orth V, Kreimeier U, Jacob M, Dressel H, Mayer S, Brechtelsbauer H, Finsterer U. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology. 2001;95:849–56.PubMedCrossRef
25.
Jacob M, Rehm M, Orth V, Lotsch M, Brechtelsbauer H, Weninger E, Finsterer U. Exact measurement of the volume effect of 6% hydroxyethyl starch 130/0.4 (Voluven®) during acute preoperative normovolemic hemodilution. Anaesthesist. 2003;52:896–904.PubMedCrossRef
26.
Rehm M, Orth V, Kreimeier U, Thiel M, Haller M, Brechtelsbauer H, Finsterer U. Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy. Anesthesiology. 2000;92:657–64.PubMedCrossRef
27.
Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA. 1991;266:1242–5.PubMedCrossRef
28.
Venn R, Steele A, Richardson P, Poloniecki J, Grounds M, Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth. 2002;88:65–71.PubMedCrossRef
29.
Varpula M, Karlsson S, Parviainen I, Ruokonen E, Pettilä V, Finnsepsis Study Group. Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand. 2007;51:1320–6.PubMedCrossRef
30.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.PubMedCrossRef
31.
Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med. 2002;30:300–5.PubMedCrossRef
32.
Friedman Z, Berkenstadt H, Preisman S, Perel A. A comparison of lactated Ringer’s solution to hydroxyethyl starch 6% in a model of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg. 2003;96:39–45.PubMedCrossRef
33.
Boura C, Caron A, Longrois D, Mertes PM, Labrude P, Menu P. Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects in skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance. Shock. 2003;19:176–82.PubMedCrossRef
34.
Moss GS, Lowe RJ, Jilek J, Levine HD. Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery (St. Louis). 1981;89:434–8.
35.
Nagy KK, Davis J, Duda J, Fildes J, Roberts R, Barrett J. A comparison of pentastarch and lactated Ringer’s solution in the resuscitation of patients with hemorrhagic shock. Circ Shock. 1993;40:289–94.PubMed
36.
Younes RN, Yin KC, Amino CJ, Itinoshe M, Rocha e Silva M, Birolini D. Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World J Surg. 1998;22:2–5.PubMedCrossRef
37.
Lowe RJ, Moss GS, Jilek J, Levine HD. Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery (St. Louis). 1977;81:676–83.
38.
Modig J. Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome: a randomized study in man after traumatic-haemorrhagic shock. Resuscitation. 1983;10:219–26.PubMedCrossRef
39.
Vincent J-L. The pros and cons of hydroxyethyl starch solutions. Anesth Analg. 2007;104:484–6.PubMedCrossRef
40.
Boldt J. Volume replacement in the surgical patient–does the type of solution make a difference? Br J Anaesth. 2000;84:783–93.PubMed
41.
Tølløfsrud S, Svennevig JL, Breivik H, Kongsgaard U, Øzer M, Hysing E, Mohr B, Seem E, Geiran O, Abdelnour M, Frøysaker T, Noddeland H. Fluid balance and pulmonary functions during and after coronary artery surgery: Ringer’s acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand. 1995;39:671–7.PubMedCrossRef
42.
Friedman G, Jankowski S, Shahla M, Gomez J, Vincent JL. Hemodynamic effects of 6 and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients. J Clin Anesth. 2008;20:528–33.PubMedCrossRef
43.
Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331:1105–9.PubMedCrossRef
44.
Mythen MG, Webb AR. Preoperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg. 1995;130:423–9.PubMed
45.
Krausz MM, Bashenko Y, Hirsh M. Crystalloid and colloid resuscitation of uncontrolled hemorrhagic shock following massive splenic injury. Shock. 2001;16:383–8.PubMedCrossRef
46.
Karanko MS. Effects of three colloid solutions on plasma volume and hemodynamics after coronary bypass surgery. Crit Care Med. 1987;15:1015–22.PubMedCrossRef
47.
Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth. 2000;47:1207–15.PubMedCrossRef
48.
Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2001;15:316–21.PubMedCrossRef
49.
Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg. 2001;92:565–71.PubMedCrossRef
50.
Van der Linden P, De Hert S, Daper A, Trenchant A, Schmartz D, Defrance P, Kimbimbi P. 3.5% Urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth. 2004;51:236–41.PubMedCrossRef
51.
Van der Linden P, De Hert S, Deraedt D, Deraedt D, Cronheecke S, De Decker K, De Paep R, Rodrigus I, Daper A, Trenchant A. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg. 2005;101:629–34.PubMedCrossRef
52.
Mortelmans YJ, Vermaut G, Verbruggen AM, Arnout JF, Vermylen J, Van Aken H, Mortelmans LA. Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Anesth Analg. 1995;81:1235–42.PubMedCrossRef
53.
Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911–6.PubMedCrossRef
54.
Molnar Z, Mikor A, Leiner T, Szakmany T. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Med. 2004;30:1356–60.PubMedCrossRef
55.
Boldt J, Heesen M, Müller M, Papsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg. 1996;83:254–61.PubMedCrossRef
56.
Boldt J, Müller M, Mentges D, Papsdorf M, Hempelmann G. Volume therapy in the critically ill: is there a difference? Intensive Care Med. 1998;24:28–36.PubMedCrossRef
57.
Palumbo D, Servillo G, D’Amato L, Volpe ML, Capogrosso G, De Robertis E, Piazza O, Tufano R. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol. 2006;72:655–64.PubMed
58.
Kuitunen A, Suojaranta-Ylinen R, Kukkonen S, Niemi T. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5), and 4% human albumin after cardiac surgery. Scand J Surg. 2007;96:72–8.PubMed
59.
Niemi T, Schramko A, Kuitunen A, Kukkonen S, Suojaranta-Ylinen R. Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg. 2008;97:259–65.PubMed
60.
Moretti EW, Robertson KM, El-Moalem H, Gan TJ. Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesth Analg. 2003;96:611–7.PubMedCrossRef
61.
Haupt MT, Rackow EC. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med. 1982;10:159–62.PubMedCrossRef
62.
Prien T, Backhaus N, Pelster F, Pircher W, Bunte H, Lawin P. Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth. 1990;2:317–23.PubMedCrossRef
63.
Rizoli SB. Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate. J Trauma. 2003;54:S82–8.PubMed
64.
Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR. Postoperative fluid overload: not a benign problem. Crit Care Med. 1990;18:728–33.PubMedCrossRef
65.
Schertel ER, Allen DA, Muir WW, Hansen BD. Evaluation of a hypertonic sodium chloride/dextran solution for treatment of traumatic shock in dogs. J Am Vet Med Assoc. 1996;208:366–70.PubMed
66.
Marx G, Cobas MM, Schuerholz T, Vangerow B, Gratz KF, Hecker H, Sumpelmann R, Rueckoldt H, Leuwer M. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med. 2002;28:629–35.PubMedCrossRef
67.
Zhang H, Voglis S, Kim CH, Slutsky AS. Effects of albumin and Ringer’s lactate on production of lung cytokines and hydrogen peroxide after resuscitated hemorrhage and endotoxemia in rats. Crit Care Med. 2003;31:1515–22.PubMedCrossRef
68.
Menger MD, Sack FU, Hammersen F, Messmer K. Tissue oxygenation after prolonged ischemia in skeletal muscle: therapeutic effect of prophylactic isovolemic hemodilution. Adv Exp Med Biol. 1989;248:387–95.PubMed
69.
Webb AR, Moss RF, Tighe D, Mythen MG, al-Saady N, Joseph AE, Bennett ED. A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis. Intensive Care Med. 1992;18:348–55.PubMedCrossRef
70.
Feng X, Yan W, Wang Z, Liu J, Yu M, Zhu S, Xu J. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage. Anesth Analg. 2007;104:624–30.PubMedCrossRef
71.
Boldt J, Zickmann B, Rapin J, Hammermann H, Dapper F, Hempelmann G. Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery. Acta Anaesthesiol Scand. 1994;38:432–8.PubMedCrossRef
72.
Neff TA, Fischler L, Mark M, Stocker R, Reinhart WH. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg. 2005;100:1773–80.PubMedCrossRef
73.
Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg. 2001;93:405–9.PubMedCrossRef
74.
Lang K, Suttner S, Boldt J, Kumle B, Nagel D. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anaesth. 2003;50:1009–16.PubMedCrossRef
75.
Martin G, Bennett-Guerrero E, Wakeling H, Kumle B, Nagel D. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer’s solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth. 2002;16:441–6.PubMedCrossRef
76.
Boldt J, Schöllhorn T, Münchbach J, Pabsdorf M. A total balanced volume replacement strategy using a new balanced hydroxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. Eur J Anaesthesiol. 2007;24:267–75.PubMedCrossRef
77.
Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A. The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Intensive Care Med. 2009;35:462–70.PubMedCrossRef
78.
Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ. 1999;316:961–4.
79.
Choi PTL, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med. 1999;27:200–10.PubMedCrossRef
80.
Roberts I, Alderson P, Bunn F, Chinnock P, Ker K, Schierhout G. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2004. doi:10.​1002/​14651858.​CD000567.​pub3.
81.
Stockwell MA, Scott A, Day A, Riley B, Soni N. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia. 1992;47:7–9.PubMedCrossRef
82.
Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethyl starch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med. 2007;35:2740–6.PubMedCrossRef
83.
Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319–34.PubMedCrossRef
84.
Boldt J, Brosch C, Röhm K, Lehmann A, Mengistu A, Suttner S. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg. 2008;107:1496–503.PubMedCrossRef
85.
Holm C. Resuscitation in shock associated with burns. Tradition or evidence-based medicine? Resuscitation. 2000;44:157–64.PubMedCrossRef
86.
Boldt J, Papsdorf M. Fluid management in burn patients: results from a European survey: more questions than answers. Burns. 2008;34:328–38.PubMedCrossRef
87.
Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317:235–40.
88.
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56.PubMedCrossRef
89.
Wilkes MM, Navickis RJ. Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;135:149–64.PubMed
90.
Alderson P, Bunn F, Lefebvre C, Li Wan Po A, Li L, Roberts I, Schierhout G, Albumin Reviewers. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004. doi:10.​1002/​14651858.​CD001208.​pub2.
91.
Coughlin MT, Angus DC. Economic evaluation of new therapies in critical illness. Crit Care Med. 2003;31:S7–16.PubMedCrossRef
92.
Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–9.PubMedCrossRef
93.
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.PubMedCrossRef
94.
Rozich JD, Paul RV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med. 1989;87:359–60.PubMedCrossRef
95.
Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726–35.PubMedCrossRef
96.
Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H. Hydroxyethyl starch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:248–9.PubMedCrossRef
97.
Cittanova ML, Leblanc I, Legendre CH, Mouquet C, Riou B, Coriat P. Effect of hydroxyethyl starch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620–2.PubMedCrossRef
98.
Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant. 1999;14:1517–20.PubMedCrossRef
99.
Blasco V, Leone M, Antonini F, Geissler A, Albanèse J, Martin C. Comparison of the novel hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth. 2008;100:504–8.PubMedCrossRef
100.
Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth. 2007;98:216–24.PubMedCrossRef
101.
Kumle B, Boldt J, Piper S, Schmidt C, Suttner S, Salopek S. The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg. 1999;89:1124–30.PubMedCrossRef
102.
Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of new starch preparation with gelatin. Intensive Care Med. 2003;29:763–9.PubMed
103.
Boldt J, Brosch C, Röhm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth. 2008;100:457–64.PubMedCrossRef
104.
Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatin during aortic aneurysm surgery. Br J Surg. 2007;94:427–33.PubMedCrossRef
105.
Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol. 2008;25:986–94.PubMedCrossRef
106.
Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg. 2002;95:544–51.PubMedCrossRef
107.
Dehne M, Muhling J, Sablotzki A, Dehne K, Sucke N, Hempelmann G. Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth. 2001;13:103–11.PubMedCrossRef
108.
Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg. 2003;96:1453–9.PubMedCrossRef
109.
Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost. 1997;78:974–83.PubMed
110.
Jonville-Bera AP, Autret-Leca E, Gruel Y. Acquired type I von Willebrand’s disease associated with highly substituted hydroxyethyl starch. N Engl J Med. 2001;345:622–3.PubMedCrossRef
111.
Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat R. Voluven®, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg. 2001;92:855–62.PubMedCrossRef
112.
Joorgensen KA, Stoffersen E. Heparin-like activity of albumin. Thromb Res. 1979;16:69–74.CrossRef
113.
Niemi T, Kuitunen A. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand. 2005;49:373–8.PubMedCrossRef
114.
Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg. 2006;102:998–1006.PubMedCrossRef
115.
Tabuchi N, de Haan J, Gallandat Huet RC, Boonstra PW, van Oeveren W. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost. 1995;74:1447–51.PubMed
116.
de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost. 1998;79:286–90.PubMed
117.
Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg. 2002;95:858–65.PubMedCrossRef
118.
Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth. 1997;78:44–50.PubMed
119.
Huttner I, Boldt J, Haisch G, Suttner S, Kumle B, Schulz H. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. Br J Anaesth. 2000;85:417–23.PubMed
120.
de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001;29:1261–7.PubMedCrossRef
121.
Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, Mullany CJ. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg. 2000;90:801–7.PubMedCrossRef
122.
Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001;72:527–33.PubMedCrossRef
123.
Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend®) on measures of coagulation. Br J Anaesth. 2002;89:722–8.PubMedCrossRef
124.
Kozek-Langenecker SA, Jungheinrich C, Sauermann W. Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg. 2008;107:382–90.PubMedCrossRef
125.
Boldt J, Schölhorn T, Mayer J, Piper S, Suttner S. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Anesth Analg. 2006;103:191–9.PubMedCrossRef
126.
Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, Gramkow CS, Okholm M, Blemmer T, Svendsen PE, Rottensten HH, Thage B, Riis J, Jeppesen IS, Teilum D, Christensen AM, Graungaard B, Pott F, Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238:641–8.PubMedCrossRef
Metadaten
Titel
Colloid solutions: a clinical update
verfasst von
Tomi T. Niemi
Ryo Miyashita
Michiaki Yamakage
Publikationsdatum
01.12.2010
Verlag
Springer Japan
Erschienen in
Journal of Anesthesia / Ausgabe 6/2010
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-010-1034-y

Weitere Artikel der Ausgabe 6/2010

Journal of Anesthesia 6/2010 Zur Ausgabe

Clinical Report

Anesthesia in a patient with mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome)

Original Article

Evaluation of tracheal intubation in several positions by the Pentax-AWS Airway Scope: a manikin study

Original Article

Predominant effects of midazolam for conscious sedation: benefits beyond the early postoperative period

Letter to the Editor

Accidental injection of remifentanil can cause a much more dangerous situation than the same dose of fentanyl

Original Article

Dexmedetomidine–ketamine and midazolam–ketamine combinations for sedation in pediatric patients undergoing extracorporeal shock wave lithotripsy: a randomized prospective study

Original Article

The LMA CTrach™ in morbidly obese and lean patients undergoing gynecological procedures: a comparative study

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise